drugset / Trial / NCT00912574

Evaluation of the Effects of Local Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in Adjuvant Administration on Dendritic Cells in Skin of Melanoma Patients and in Sentinel Lymph Nodes: MEL38

NCT00912574

Completed 29 enrolled University of Virginia
RandomizedSingle-groupOpen-labelTreatment

Summary

Goal: To characterize the cellular events that occur in vivo after vaccination with an emulsion of GMCSF-in-adjuvant. Design: Open-label, single dose study in two stages.

Timeline

Start
2004-06
Primary completion
2008-07
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator incomplete Freund's adjuvant Other / unclassified 0.5 ml Other
Comparator sargramostim Protein / enzyme biologic Other

Indications